https://www.worldpharmatoday.com/drug-research/boehringer-ingelheim-and-eli-lilly-company-plans-to-conduct-jardiance-empagliflozin-to-be-studied-for-the-treatment-of-people-with-chronic-heart-failure/ Magazine for the C-level Pharma Executives Mon, 18 Apr 2016 18:30:00 +0000 hourly 1 https://wordpress.org/?v=6.9.4